The largest ever clinical trial of T cell therapy for solid tumors has ended, heralding a new era for precision T cell therapy.
Alzheimer’s drug approvals show we need a reevaluation of patient advocacy
When faced with a loved one’s progressive neurodegenerative disease, like Alzheimer’s, or your child’s rare respiratory disease, you question why researchers and resource-backed pharma cannot